Login / Signup

Treatment-related mortality following autologous hematopoietic stem cell transplantation is unaffected by timing of G-CSF administration.

Naveed AliBrenda CooperBenjamin TomlinsonLeland L MethenyPaolo CaimiKirsten BoughanMolly GalloglyFolashade OtegbeyeEhsan MalekHillard LazarusRichard CregerMarcos J deLima
Published in: Bone marrow transplantation (2020)
Keyphrases
  • bone marrow
  • risk factors
  • type diabetes
  • mesenchymal stem cells
  • coronary artery disease